Zum Inhalt wechseln
yumab-logo
  • Company
    • We are YUMAB
    • Partnering
    • Career
  • Services
    • Antibody Libraries
    • Antibody Discovery
    • Antibody Engineering
    • Antibody Humanization
  • Technologies
  • Newsroom
  • Contact

Kategorie: Literature Digests

Novel NKG2D-targeting bispecific antibodies improve B cell lymphoma killing

In collaboration with the universities of Kiel, Munich, and Braunschweig, a novel bispecific antibody CD20xNKG2D was developed to enhance lymphocyte recruitment and mediate killing of B cell lymphoma cells. Read more

PROxAbs: Next generation PROTACs to access difficult targets

In collaboration with YUMAB, scientists from Merck KGaA have developed a PROTAC-Antibody shuttle (PROxAb) to improve efficacy and therapeutic applicability of PROTACs. Read more

youtube-icon
linkedin-icon

YUMAB GmbH

  • Science Campus Braunschweig-Süd
    Inhoffenstr. 7
    38124 Braunschweig
    Germany


  • (+49) 531 481170 0
  • info@yumab.com
  • Legal notice
  • Disclaimer, Data Privacy Statement
  • Terms and Conditions